ICD-10-CM Billable Code

F15.281

Other stimulant dependence with stimulant-induced sexual dysfunction

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F15.281 refers to a condition characterized by dependence on stimulants along with sexual dysfunction caused by stimulant use. Stimulants are substances that enhance alertness, attention, and energy, but prolonged or excessive use can lead to dependence and other health issues. This condition highlights the complex relationship between stimulant addiction and sexual health problems, emphasizing the need for comprehensive treatment approaches.

Causes & Symptoms

Clinical Causes: Chronic use of stimulant substances such as cocaine, methamphetamine, or prescription medications like Adderall or Ritalin. Repeated use leading to physical dependence, characterized by cravings and withdrawal symptoms. Altered brain chemistry due to prolonged stimulant exposure affecting sexual functions. Psychological factors such as stress, anxiety, or mood disorders that may contribute to substance use and sexual dysfunction. Environmental and social factors influencing substance use behaviors and sexual health.

Key Symptoms: Persistent dependence on stimulant substances despite negative effects. Difficulty controlling or reducing stimulant intake. Impaired sexual function, including decreased libido, erectile dysfunction, or anorgasmia. Reduced sexual satisfaction or performance during stimulant use. Physical or psychological withdrawal symptoms when not using stimulants. Mood changes, irritability, or anxiety related to substance use or sexual performance problems.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive medical and psychiatric evaluation to assess substance use history, patterns of dependency, and sexual health concerns. Healthcare providers may utilize medical history, physical examination, laboratory tests, and psychological assessments to determine the presence of stimulant dependence and sexual dysfunction related to substance use. The condition is identified when stimulant dependence coexists with measurable sexual performance issues directly associated with stimulant use.

Treatment Protocols: Managing this condition typically involves a multifaceted approach targeting both stimulant dependence and sexual dysfunction. Treatment options may include: - **Detoxification and abstinence support**: Medical supervision during withdrawal, if necessary. - **Behavioral therapies**: Cognitive-behavioral therapy (CBT), motivational interviewing, or contingency management to address substance dependence. - **Medications**: No specific medications are approved for stimulant dependence, but certain drugs may help reduce cravings or manage co-occurring mental health conditions. - **Sexual health counseling**: Addressing sexual dysfunction through therapy or medical interventions. - **Support groups**: Peer support organizations to encourage sustained recovery. A tailored treatment plan developed by healthcare professionals aims to reduce stimulant use and improve sexual health and overall well-being.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F15.281 a billable ICD-10 code?
Yes, F15.281 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F15.281?
Clinical documentation must specify the nature of Other stimulant dependence with stimulant-induced sexual dysfunction and any associated comorbidities for accurate reporting.

Cite this Clinical Reference